Assignee
BRIGHTGENE BIO MEDICAL TECH CO LTD
CN·13 granted patents·4 pending applications·16 citations·filing 2015–2023
Top patents by PatentIndex Score
17 records- 0186US10869863B2Multi-arm polymeric targeting anti-cancer conjugateBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2017·Granted Dec 22, 2020·3 cites·17 claims
- 0285US10538541B2Phosphoramidate compound and preparation method and crystal thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2016·Granted Jan 21, 2020·6 cites·14 claims
- 0384US10072122B2Carbonate polymer containing a functional group of disulfide five-membered ring in the side chain and application thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2015·Granted Sep 11, 2018·3 cites·8 claims
- 0481US10689413B2Composition enriched in single isomer of NUC-1031 and preparation method and use thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2016·Granted Jun 23, 2020·4 cites·10 claims
- 0564US12215133B2GIP and GLP-1 dual receptor agonist, pharmaceutical composition, and useBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2023·Granted Feb 4, 2025·0 cites·8 claims
- 0664US10913756B2Phosphoramidate compound and preparation method and crystal thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2019·Granted Feb 9, 2021·0 cites·19 claims
- 0754US12551565B2CD44 targeted multi-arm conjugateBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2020·Granted Feb 17, 2026·0 cites·20 claims
- 0851US9796728B2Cyclic carbonate monomer containing double-sulfur five-membered ring functional group, and preparation method thereofBRIGHTGENE BIO-MEDICAL TECH CO LTD·Filed 2015·Granted Oct 24, 2017·0 cites·8 claims
- 0950US10759905B2Biodegradable amphiphilic polymer, polymeric vesicles prepared therefrom, and application of biodegradable amphiphilic polymer in preparation of medicines for targeted therapy of lung cancerBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2016·Granted Sep 1, 2020·0 cites·9 claims
- 1049US2024209056A1Gip and glp-1 dual receptor agonist, pharmaceutical composition, and useBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 1145US10292940B2Hyaluronic acid-based amphiphilic polymer, preparation method and application thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2016·Granted May 21, 2019·0 cites·11 claims
- 1245US2022064141A1Benzopyridone heterocyclic compound and use thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2020·Application pending·0 cites
- 1344US12122784B2Preparation method for ecteinascidin compound and intermediate thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2019·Granted Oct 22, 2024·0 cites·25 claims
- 1444US11191843B2Multi-arm targeting anti-cancer conjugateBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2018·Granted Dec 7, 2021·0 cites·18 claims
- 1543US2018360766A1Ovarian cancer specifically targeted biodegradable amphiphilic polymer, polymer vesicle prepared thereby and use thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2018·Application pending·0 cites
- 1635US11179467B2Exenatide modifier and use thereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2016·Granted Nov 23, 2021·0 cites·2 claims
- 1732US2018237466A1Preparation Method of Nucleoside Phosphoramidate Prodrugs and Intermediates ThereofBRIGHTGENE BIO MEDICAL TECH CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BRIGHTGENE BIO MEDICAL TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →